Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- Check3 days agoChange DetectedThe revision history now includes the latest revision entry, v3.6.5, and drops the previous v3.6.4. This reflects an update to the page's revision metadata rather than any user-facing content change.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe history section now shows Revision: v3.6.4, replacing the previous v3.6.3. This denotes an update to the page's versioning rather than to study data.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe revision line was updated from v3.6.2 to v3.6.3, indicating a newer version of the page. This reflects an update to the page's revision history interface rather than changes to the study record data.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision tag v3.6.2 was added and the old v3.6.0 tag was removed on the page, indicating a small update to the revision history display.SummaryDifference0.1%

- Check60 days agoChange DetectedA new recruitment-status entry 'No longer looking for participants' was added. The revision was updated to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.3%

- Check67 days agoChange DetectedThe history now includes a new revision entry for v3.5.5, and the previous revision entry v3.5.4 was removed from the current history view.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.